|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 58.97M 4.54M 4.17M 3.89M 7.38M 495M 7.49M 50.12M 19.48M 243M 19.5M 19.09M 838M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 119M 9.13M 8.39M 7.82M 14.84M 995M 15.06M 101M 39.17M 489M 39.21M 38.37M 1.68B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | ||
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | ||
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | ||
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | ||
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | ||
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | ||
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | ||
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | ||
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | ||
| Average | +2.10% | +4.58% | +31.78% | +58.22% | 369.24B | |
| Weighted average by Cap. | +2.25% | +5.53% | +42.31% | +83.31% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 101M 7.77M 7.14M 6.66M 12.63M 847M 12.82M 85.77M 33.34M 416M 33.38M 32.66M 1.43B | 9.91M 112M 8.66M 7.96M 7.42M 14.08M 944M 14.29M 95.58M 37.15M 464M 37.2M 36.4M 1.6B |
| Net income | 665K 7.55M 581K 534K 498K 945K 63.32M 959K 6.41M 2.49M 31.13M 2.5M 2.44M 107M | 762K 8.64M 666K 612K 570K 1.08M 72.51M 1.1M 7.34M 2.86M 35.64M 2.86M 2.8M 123M |
| Net Debt | 4.15M 47.06M 3.63M 3.33M 3.11M 5.89M 395M 5.98M 40M 15.55M 194M 15.57M 15.23M 669M | 5.25M 59.58M 4.59M 4.22M 3.93M 7.46M 500M 7.57M 50.63M 19.68M 246M 19.71M 19.28M 847M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















